1. bookVolume 62 (2012): Edition 3 (September 2012)
Détails du magazine
Première parution
28 Feb 2007
4 fois par an
Accès libre

Semicarbazone – a versatile therapeutic pharmacophore for fragment based anticonvulsant drug design

Publié en ligne: 06 Nov 2012
Volume & Edition: Volume 62 (2012) - Edition 3 (September 2012)
Pages: 263 - 286
Détails du magazine
Première parution
28 Feb 2007
4 fois par an

1. M. Meonardi and T. Ustun, The global burden of epilepsy, Epilepsia 43 (2002) 21_25; DOI: 10. 1046/j.1528-1157.43.s.6.11.x.Search in Google Scholar

2. R. Sridharan and B. N. Murthy, Relevance and pattern of epilepsy in India, Epilepsia 40 (1999) 631_636; DOI: 10.1111/j.1528-1157.1999.tb05566x.Search in Google Scholar

3. G. F. Carl and M. L. Smith, Phenytoin-folate interaction differing effect of the sodium salt and the free acid of phenytoin, Epilepsia 33 (1992) 372_375; DOI: 10.1111/j.1528-1157.1992tb02330x.Search in Google Scholar

4. P. Kwan and M. J. Brodie, Phenobarbital for the treatment of epilepsy in the 21st century, a critical review, Epilepsia 45 (2004) 1141_1149; DOI: 10.1111/j.0013-9580.2004.12704.x.10.1111/j.0013-9580.2004.12704.xSearch in Google Scholar

5. S. D. Shorvon, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959_2009, Epilepsia 50 (suppl. 3) (2009) 93_130; DOI: 10.1111/j.1528-1167.2009.02042.x.10.1111/j.1528-1167.2009.02042.xSearch in Google Scholar

6. A. C. Foster and J. A. Kemp, Glutamate and GABA-based CNS therapeutics, Curr. Opin. Pharmacol. 6 (2006) 7_17.Search in Google Scholar

7. M. Mazza, G. Della Marcla and M. DiNicola, Oxacarbazepine improves mood in the patients with epilepsy, Epilepsy Behav. 10 (2007) 397_401; DOI: 10.1016/j.yebeh.2007. in Google Scholar

8. J. M. Rho, S. D. Donevan and M. A. Rogawaski, Barbiturate like action of the propanediol dicarbamate felbamate and meprobamate, J. Pharmacol. Exp. Ther. 280 (1997) 1383_1391.Search in Google Scholar

9. C. Salome, E. Salome-Grosjean, J. P. Stables and H. Kohn, Merging the structural motifs of functionalized amino acids and alpha amino amides: compounds with significant anticonvulsant activities, J. Med. Chem. 53 (2010) 3756_3771; DOI: 10.1021/jm 100185c.Search in Google Scholar

10. A. C. Errington, L. Coyne, T. Stohr, N. Selve and G. Lees, Seeking a mechanism of action for the novel anticonvulsant lacosamide, Neuropharmacology 50 (2006) 1016_1024; DOI: 10.1016/j.neuropharm. 2006.02002.Search in Google Scholar

11. R. G. Fariello, Safinamide, Neurotherapeutics 4 (2007) 110_116; DOI: 10.1016/j.nurt.2006. in Google Scholar

12. N. D. Eddington, D. S. Cox, R. R. Roberts, J. P. Stables, C. B. Powells and K. R. Scott, Enaminonesversatile therapeutic pharmacophores, Further advances, Curr. Med. Chem. 4 (2000) 417_436.Search in Google Scholar

13. S. N. Pandeya and J. R. Dimmock, Recent evaluation of thiosemicarbazones and semicarbazones and related compounds for antineoplastic and anticonvulsant activities, Pharmazie 48 (1993) 659_666.Search in Google Scholar

14. H. Beraldo and D. Gambino, The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes, Mini Rev. Med. Chem. 4 (2004) 31_39.Search in Google Scholar

15. L. Liu, T. Zeng, M. J. Morris, C. Wallengren, A. L. Clarke, C. A. Reid, S. Petrou and T. J. O’Brien, The mechanism of carbamazepine aggravated of absence seizures, J. Pharmacol. Expt. Ther. 319 (2006) 790_798; DOI: 10.1124/jpet.106.10496.Search in Google Scholar

16. S. N. Ghalmi, D. A. Berv, J. Klugman, K. J. Rosenquist and D. J. Hsu, Oxacarbazepine. Treatment of bipolar disorder, J. Clin. Psychiatry 64 (2003) 943_945; DOI: 10.4088/JCP.v64n0813.10.4088/JCP.v64n0813Search in Google Scholar

17. C. Dulsat, N. Mealy, R. Castaner and J. Bolos, Eslicarbazepine acetate. Drugs Fut. 34 (2009) 189_199; DOI: 10.1358/dof.2009.034.03.1352675.10.1358/dof.2009.034.03.1352675Search in Google Scholar

18. D. Schmidt and K. Utech, Progabide for refractory partial epilepsy: A controlled add-on trial, Neurology 36 (1986) 217_221.Search in Google Scholar

19. S. C. Vashishtha, G. A. Zello, K. H. Nienaber, J. Balzarini, E. D. Clercq, J. P. Stables and J. R. Dimmock, Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds, Eur. J. Med. Chem. 39 (2004) 27_35.Search in Google Scholar

20. S. K. Sridhar, S. N. Pandeya, J. P. Stables and A. Ramesh, Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives, Eur. J. Pharm. Sci. 16 (2002) 129_132.Search in Google Scholar

21. F. D. Popp, Potential anticonvulsants, VII Some hydrazones of indole-3-carboxaldehyde, J. Het. Chem. 21 (1984) 617_619.Search in Google Scholar

22. J. Jain, Y. Kumar, R. Sinha, R. Kumar and J. Stables, Menthone aryl acid hydrazones: A new class of anticonvulsants, Med. Chem. 7 (2011) 56_61.Search in Google Scholar

23. J. O. McNamara, Drugs Effective in the Therapy of Epilepsy, in Goodman and Gilman’s Pharmaceutical Basis of Therapeutics (Ed. J. G. Hardman, L. E. Limbird, P. B. Molinoaff and R. W. Ruddon), 9th ed., McGraw Hill, New York 2001, pp. 461_486.Search in Google Scholar

24. S. Coker, The use of phenacemide for intractable partial complex epilepsy in children, Pediatr. Neurol. 2 (1986) 230_232; DOI: 10.1016/0887-8994(86)90053-6.10.1016/0887-8994(86)90053-6Search in Google Scholar

25. T. R. Browne, „Fosphenytoin (cerebyx), Clin. Neuropharm. 20 (1997) 1_12; DOI: 10.1097/00002826-199702000-00001.10.1097/00002826-199702000-000019037568Search in Google Scholar

26. P. N. Patsalos, Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies, Epilepsia 46 (S9) (2005) 140_144; DOI: 10.1111/j.1528-1167.2005.00326.x.10.1111/j.1528-1167.2005.00326.x16302888Search in Google Scholar

27. R. Kaliviainen, K. Eriksson and I. Parviainan, Refractory generalized convulsive status epileptics: a guide to treatment, CNS Drugs 19 (2005) 759_768; DOI: 10.2165/00023210-200519090-00003.10.2165/00023210-200519090-0000316142991Search in Google Scholar

28. J. R. Dimmock, R. N. Pathucode, J. Tuchck and G. B. Baker, Anticonvulsant activities of 4(4’-fluorophenyl) benzaldehyde semicarbazones, Drug Dev. Res. 46 (1999) 112_125.Search in Google Scholar

29. Y. Wang, S. X. Cai and J. F. W. Keanaan, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 638, 947, 28 Oct 2003.Search in Google Scholar

30. J. R. Dimmock, Semicarbazones having CNS activity and pharmaceutical preparations containing same, U.S. Pat. 5, 741, 818, 21 Apr. 1998.Search in Google Scholar

31. Y. Wang, S. X. Cai, N. C. Lam, J. F. W. Keanan, VI Ilynin and E Weber, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 613, 803, 2 Sept 2003.Search in Google Scholar

32. S. X. Cai, N. C. Lam and S. Hongbal, Substituted semicarbazides and the use thereof, U. S. Pat. 6, 281, 211, 28 Aug 2001.Search in Google Scholar

33. S. N. Pandeya, V. Mishra, P. N. Singh and D. C. Rupainwar, Anticonvulsant activity of thiouriedo derivatives of acetophenone semicarbazone, Pharmacol. Res. 37 (1998) 17_22.Search in Google Scholar

34. V. I. Ilynin, J. D. Ponionis, G. T. Whiteside, J. E. Harrison, M. S. Meason, L. Mork, P. E. Turdin, S. Cooh, R. B. Caster, P. Nguyen, D. S. Hogencamp, S. Olanreqwajn, E. Benzamin and R. N. Woodward, Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy) phenyl]-pyrimidine-4-carboxamide (PPPA): A Potent, broad spectrum state dependent sodium channel blocker for treating painstates, J. Pharmacol. Exp. Ther. 318 (2006) 1086_1093.Search in Google Scholar

35. J. R. Dimmock, R. N. Puthucode, M. S. Lo, J. W. Quail, J. Yang and J. P. Stables, Structural modification of the primary amino group of anticonvulsant aryl semicarbazones, Pharmazie 51 (1996) 83_88.Search in Google Scholar

36. S. N. Pandeya, N. Aggarwal and J. S. Jain, Evaluation of semicarbazones for anticonvulsant and sedative hypnotic properties, Pharmazie 54 (1999) 300_312.Search in Google Scholar

37. S. N. Pandeya, V. Mishra, I. Ponnilavarsan and J. P. Stables, Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones - the role of primary terminal amino group, Pol. J. Pharmacol. 52 (2000) 283_290.Search in Google Scholar

38. S. N. Pandeya, P. Yogeeswari and J. P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted arylsemicarbazones, Eur. J. Med Chem. 35 (2000) 879_886.Search in Google Scholar

39. P. Yogeeswari, J. V. Raghvendran, R. Thirumurugan, S. Induja, D. Sriram and J. P. Stables, Synthesis and structure activity relationship on anticonvulsant arylsemicarbazones, Med. Chem. 2 (2006) 55_62.Search in Google Scholar

40. J. Jain, Y. Kumar, J. P. Stables and R. Sinha, Menthone semicarbazides and thiosemicarbazides as anticonvulsant agents, Med. Chem. 6 (2010) 44_50.Search in Google Scholar

41. K. Verma, S. N. Pandeya, V. K. Singh, S. Gupta, P. Prashant, Anurag and G. Bhardwaj, Synthesis and pharmacolgical activity of some substituted menthone semicarbazones and thiosemicarbazone derivatives, Int. J. Pharm. Sci. Nanotech. 1 (2009) 357_362.Search in Google Scholar

42. H. P. Singh, C. S. Chauhan, S. N. Pandeya and C. S. Sharma, Chalcone semicarbazone: a new scaffold for antiepileptic drug discovery, J. Chil. Chem. Soc. 55 (2010) 103_106; DOI: 10.4067/50717-970720 10000 100024.Search in Google Scholar

43. H. P. Singh, S. N. Pandeya, C. S. Chauhan and C. S. Sharma, Synthesis and pharmacological screening of some novel chalconyl derivatives of substituted phenylsemicarbazide, Med. Chem. Res.; DOI: 1007/S00044-000-9277-6.Search in Google Scholar

44. H. P. Singh, C. S. Chauhan, S. N. Pandeya, C. S. Sharma, B. Srivastava and M. Singhal, Synthesis and pharmacological screening of some novel chloro chalcone semicarbazone derivatives, Pharm. Chem. 2 (2010) 343_357.Search in Google Scholar

45. S. N. Pandeya, A. K. Agrawal, A. Singh and J. P. Stables, Design and synthesis of semicarbazones and their sioisosteric analogues as potent anticonvulsant: The role of hydrogen bonding, Acta Pharm. 53 (2003) 15_24.Search in Google Scholar

46. P. Yogeeswari, D. Sriram, S. N. Pandeya and J. P. Stables, 4-Sulphamoyl semicarbazones with anticonvulsant activity, Farmaco 59 (2004) 609_613; DOI: 10.1016/j.farmac.2004. in Google Scholar

47. R. Thirumurugan, D. Sriram, A. Saxena, J. P. Stables and P. Yogeeswari, 2,4-Dimethoxy phenylsemicarbazones with anticonvulsant activity against three animal models of seizures. Synthesis and pharmacological evaluation, Bioorg. Med. Chem. 9 (2006) 3106_3112.Search in Google Scholar

48. P. Yogeeswari, R. Thirumurugan, R. Kavya, J. S. Samuel and J. P. Stables, 3-Chloro-2-methyl phenyl substituted semicarbazones: Synthesis and anticonvulsant activity, Eur. J. Med. Chem. 39 (2004) 729_734.Search in Google Scholar

49. P. Yogeeswari, D. Sriram, V. Veena, R. Kavya, R. Rakhra, J. V. Raghvendran, S. Mehta, R. Thirumurugan and J. P. Stables, Synthesis of arylsemicarbazones as potential anticonvulsants agents, Biomed. Pharmacother. 59 (2005) 57_55; DOI: 10.1016/j.biopha 2004.04.013.Search in Google Scholar

50. S. N. Pandeya, I. Ponnilavarasan, A. Pandey, R. Lakhan and J. P. Stables, Evaluation of p-nitrophenyl substituted semicarbazones for anticonvulsant properties, Pharmazie 54 (1999) 923_925.Search in Google Scholar

51. N. Aggarwal, P. Mishra, B. P. Nagori, R. Aggrawal and J. Jain, Anticonvulsant and neurotoxicity evaluation of some N(4)-phenylsubstituted pyridyl semicarbazones, CNS Agents Med. Chem. 9 (2009) 245_249; DOI: 10.1016/j.ejps 2003.08.002.Search in Google Scholar

52. A. S. Raja, S. N. Pandeya, S. S. Panda and J. P. Stables, Synthesis and anticonvulsant evaluation of semicarbazones of acetophenone Mannich bases, Pharm. Chem. J. 41 (2007) 302_307.Search in Google Scholar

53. S. Mehta, P. Yogeeswari, D. Sriram and S. Induja, Microwave-assisted synthesis, anticonvulsant activity and quantum mechanical modeling of N-(4-bromo-3-methyl phenyl) semicarbazones, J. Zhegiang. Univ. Sec. B, 8 (2007) 45_55; DOI: 10.1631/ZUS 2007.B0045.Search in Google Scholar

54. S. Mehta, P. Yogeeswari, D. Sriram, P. Kendyer, P. R. Kumar, S. Induja and J. P. Stables, Quantum mechanical modelling of N4-(2,5-disubstituted phenyl) semicarbazones: Synthesis and anticonvulsant activity of N4-(2,5-dimethyl phyenyl/2-fluoro-5-methyl phenyl) semicarbazones, Med. Chem. 2 (2006) 617_625.Search in Google Scholar

55. P. Yogeeswari, D. Sriram, R. Thirumurugan, J. V. Ragvendran, K. Sudhansu and J. P. Stables, Discovery of N-[2,6-dimethylphenyl) substituted semicarbazones as anticonvulsant effective against various animal model of seizures with GABA-T-inhibitory activity, J. Med. Chem. 48 (2005) 6202_6211; DOI: 10.1021/jm050283b.10.1021/jm050283b16190747Search in Google Scholar

56. F. Azam, T. A. Alkaskas, S. L. Khokra and O. Prakash, Synthesis of novel N1-(naphtha[1,2-d] thiazol-2-yl) semicarbazides as potential anticonvulsant, Eur. J. Med. Chem. 44 (2009) 203_211.Search in Google Scholar

57. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat and S. E. Haque, Synthesis of benzthiazole semicarbazones as novel anticonvulsant. The role of hydrophobic domain, Bioorg. Med. Chem. Lett. 17 (2007) 4178_4182; DOI: 10.1002/ardp.200800130.10.1002/ardp.20080013019194967Search in Google Scholar

58. S. Mehta, R. K. Pavana, P. Yogeeswari, D. Sriram, J. P. Stables, Heteroaryl-substituted semicarbazones. Synthesis and anticonvulsant activity of N-(3-methyl pyridine-2-yl)-substituted semicarbazones, J. Heter. Chem. 43 (2009) 1287_1293; DOI: 10.1002/jRet 5570430522.Search in Google Scholar

59. N. Aggarwal and P. Mishra, Synthesis and evaluation of 4-substituted Semicarbazones of levulinic acid for anticonvulsant activity, J Zhejiang Univ. Sci. B. 6 (2005) 617_621; DOI: 10.1631/jZUS.2005.B0617.10.1631/jzus.2005.B0617138979315973761Search in Google Scholar

60. M. Taroua, C. Ribuot, M. H. Pera, G. Tailandier, M. Fatome, J. D. Laval, P. Demengec and G. Leclerc, New _-, _- and _-semicarbazone and thiosemicarbazone 1,3-dithiolones as radioprotectors anticonvulsant activity, Eur. J. Med. Chem. 31 (1996) 589_595; DOI: 10.1002chin.1996 461 40.Search in Google Scholar

61. H. Rajak, R. Deshmukh, N. Aggarwal, S. Kashaw, M. D. Kharya and P. Mishra, Synthesis of novel 2,5-disubstituted-1,3,4-thiadiazoles for their potential anticonvulsant activity: Pharmacophoric model studies, Arch. Pharm. Pharm. Med. Chem. (Weinheim) 342 (2009) 453_461.10.1002/ardp.20080021319565600Search in Google Scholar

62. N. Siddiqui, M. F. Arshad and S. A. Khan, Synthesis of some new coumarin incorporated thiazoylsemicarbazones as anticonvulsants, Acta Pol. Pharm. 66 (2009) 161_167.Search in Google Scholar

63. I. Ponnilavarasan, S. Ganguly and V. Pandit, Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsants and antimicrobial agents, J. Pharm. Res. 3 (2010) 703_706.Search in Google Scholar

64. J. R. Dimmock and G. B. Baker, Anticonvulsant activities of 4-bromobenzaldehyde semicarbazones, Epilepsia 35 (1994) 648_655; DOI: 10.1111/j.1528-1157.1994.tb02486x.Search in Google Scholar

65. S. N. Pandeya, H. Manjula and J. P. Stables, Design of semicarbazones and their bio-isosteric analogues as potential anticonvulsants, Pharmazie 56 (2001) 121_124.Search in Google Scholar

66. S. N. Pandeya, B. N. Singh and J. Mishra, Synthesis and biological activity of substituted arylsemicarbazones, Acta Sci. Ind. XXXIIIC (2007) 85_92.Search in Google Scholar

67. S. N. Pandeya, S. Smitha and J. P. Stables, Anticonvulsant and sedative-hypnotic activities of N-substituted isatin semicarbazones, Arch. Pharm. (Weinheim) Pharm. Med. Chem. 4 (2002) 129_134; DOI: 10.1002/1521-4184(200204).Search in Google Scholar

68. S. N. Pandeya, S. Kohli, N. Siddiqui and J. P. Stables, Synthesis and anticonvulsant activities of 4-N-substituted arylsemicarbazones, Pol. J. Pharmacol. 55 (2003) 565_571.Search in Google Scholar

69. S. N. Pandeya, A. S. Raja and J. P. Stables, Synthesis of isatin semicarbazones as novel anticonvulsant role of hydrogen bonding, J. Pharm. Pharm. Sci. 5 (2002) 266_271.Search in Google Scholar

70. A. Singh, C. Pande, P. Gahtori, S. N. Pandeya and J. P. Stables, Design and synthesis of some novel 4(4-substituted aryl) semicarbazones as anticonvulsant agents, Indian J. Pharm. Sci. 72 (2010) 363_367; DOI: 10.4103 10250-474x70485.Search in Google Scholar

71. N. Aggarwal and P. Mishra, Synthesis of 4-arylsubstituted semicarbazones of some terpenes as novel anticonvulsants, J. Pharm. Pharm. Sci. 7 (2004) 260_264.Search in Google Scholar

72. N. Aggrawal, R. Aggarwal, P. Mishra, J. S. Jain, S. K. Bansal and K. K. Jha, Design and evaluation of semicarbazones and thiosemicarbazones as novel anticonvulsants, CNS Agents Med. Chem. 8 (2008) 26_28.Search in Google Scholar

73. J. R. Dimmock, K. K. Sidhu, R. S. Thayer, P. Mack, M. J. Duffy, R. S. Reid, J. W. Quail, U. Pugazhenthi, A. Ong, J. A. Bikker and D. F. Weaver, Anticonvulsant activities of some arylsemicarbazones, displaying potent oral activity in the maximal electroshock screen in rats acconpanied by high protective indices, J. Med. Chem. 36 (1993) 2243_2265; DOI: 10.1021/jm000689001.Search in Google Scholar

74. J. R. Dimmock, K. K. Sidhu, S. D. Thumber, S. D. Basram, M. Chen, J. W. Quail, J. Yang, I. Rozas and D. F. Weaver, Some arylsemicarbazones possessing anticonvulsant activity, Eur. J. Med. Chem. 30 (1995) 287_301.Search in Google Scholar

75. J. R. Dimmock, R. N. Puthucode, J. M. Smith, M. Hetherington, J. W. Quail, U. Pugazhenthi, R. Lecher and J. P. Stables, (Aryloxy) aryl semicarbazones and related compounds: A novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen, J. Med. Chem. 39 (1996) 3984_3997; DOI: 10.1021/jm9603025.10.1021/jm96030258831764Search in Google Scholar

76. R. N. Puthucode, U. Pugazenthi, J. W. Quail, J. P. Stables and J. R. Dimmock, Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones, Eur. J. Med. Chem. 33 (1998) 595_607.Search in Google Scholar

77. J. R. Dimmock, H. A. Semple, S. John, M. A. Beazely and G. D. Abrams, Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy)benzaldehyde semicarbazones after oral dosing to rats, Pharmazie 54 (1999) 260_262.Search in Google Scholar

78. K. Ramu, G. N. Lam and H. Huges, In vivo metabolism and mass balance of 4[4-fluorophenylbenzaldehyde semicarbazone (CO102862) in rats, Drug Metab. Dispos. 28 (2000) 1153_1161.Search in Google Scholar

79. K. Ramu, G. N. Lam and B. Chin, Development of a high-performance liquid chromatorgraphy tandem mass spectrum of the method for the determination of pharmacokinetic of C0102802 in mouse, rat, monkey and dogs plasma, J. Chromatogr. 741 (2000) 1_15.Search in Google Scholar

80. N. C. Lam, Sodium channel blocker compositions and the use thereof, Pat. W0 00/6 11 88, 19 Oct. 2000.Search in Google Scholar

81. N. Micale, M. Zappala, S. Grazzo, G. Puja, G. Desarro, G. Ferreri, A. Desarro, L. Toma and C. Di Michali, Novel potent AMP/Kainate receptor antagonists : Synthesis and anticonvulsant activity of series of 2[(4-alkyl semicarbazono)-(4-aminophenyl) methyl)-4,5-methylene dioxy phenylacetic acid alkyl esters, J. Med. Chem. 45 (2002) 4433_4442.Search in Google Scholar

82. N. Siddiqui, M. S. Alam and W. Ahsan, Synthesis, Anticonvulsant and toxicity evaluation of 2(1H-indol-3yl)acetyl-N-substituted phenyl) hydrazine carbothioamides and their related heterocyclic derivatives, Acta Pharm. 58 (2008) 445_459; DOI: 10.2478/v1007-008-0025-0.5.Search in Google Scholar

83. S. Mehta, P. Yogeeswari, D. Sriram and J. P. Stables, Cyclization of the semicarbzone template of arylsemicarbazones: Synthesis and anticonvulsant activity of 4,5-(diphenyl)-2H-1,2,4-triazole-3-(4H)-one, Biomed. Pharmacother. 63 (2009) 187_193; DOI: 10.1016/j.biopha.2006. in Google Scholar

84. P. Czapinski, B. Blaszezyk and S. J. Czuczwar, Mechanism of action of antiepileptic drugs, Curr. Top. Med. Chem. 5 (2005) 3_14.10.2174/156802605338696215638774Search in Google Scholar

85. V. I. Ilyin, D. D. Hodges, E. R. Whitmore, R. B. Carter, S. X. Cai and R. M. Woodward, V102862 (CO102862): A potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels, Br. J. Pharmacol. 144 (2005) 801_812; DOI: 10.1038/sj.bjp.0706058.10.1038/sj.bjp.0706058157606115778702Search in Google Scholar

86. P. Yogeeswari, D. Sriram, A. Brahmanandan, I. Sridharan, R. Thirumurugan and J. P. Stables, Synthesis of novel arylsemicarbazones as anticonvulsants with GABA-mediated mechanism, Med. Chem. Res. 12 (2003) 57_68.Search in Google Scholar

87. W. E. Stone and M. J. Javid, Quantititative evaluation of the action of anticonvulsants against different chemical convulsants, Arch. Int. Pharmacodyn. Ther. 240 (1979) 66_78.Search in Google Scholar

88. W. E. Stone and M. J. Javid, Anticonvulsant and convulsive effects of lidocaine: Comparison with those of phenytoin, and implication for mechanism of action concepts, Neurol. Res. 10 (1988) 161_168.Search in Google Scholar

89. R. L. McDonald and K. M. Kelly, Antiepileptic drug mechanism of action, Epilepsia 36 (Suppl. 2S) (1995) 2_12.10.1111/j.1528-1157.1995.tb05996.x8784210Search in Google Scholar

90. P. Yogeeswari, J. V. Ragavendran, D. Sriram, V. Nageswari, R. Kavya, N. Srivastsan, K. Vanitha and J. P. Stables, Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach, J. Med. Chem. 50 (2007) 2459_2467; DOI: 10.1021/jm061431g.10.1021/jm061431g17451232Search in Google Scholar

91. B. Malawaska and A. Scatturin, Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs, Mini Rev. Med. Chem. 3 (2003) 341_348.Search in Google Scholar

92. J. Riss, J. Cloyd, J. Gates and S. Collins, Benzodiazepines in epilepsy pharmacology and pharmacokinetics, Acta Neurol. Scand. 118 (2008) 64_86; DOI: 10.1111/j.1600-0404.2008.01004.x.10.1111/j.1600-0404.2008.01004.x18384456Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo